Under the microscope: Transforming drug discovery on membrane proteins

Our CEO, Line Stigen Raquet, and Michael Hennig from leadXpro sat together and discussed why leadXpro chose the WAVEsystem back in 2017 and how this partnership is creating first‑of‑a‑kind kinetic dataRead all about it on Drug Target Review

Last modified onWednesday, 16 September 2020 09:58